| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $176.0M | +39.9% |
| Cost of Revenue | $40.8M | +30.2% |
| Gross Profit | $135.2M | +43.1% |
| R&D Expense | $64.9M | +49.2% |
| SG&A Expense | $134.3M | +19.8% |
| Operating Income | -$64.1M | -4.6% |
| Pre-tax Income | -$116.9M | -21.3% |
| Income Tax | -$76K | -243.4% |
| Net Income | -$116.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.8M | -12.8% |
| Short-term Investments | $132.0M | — |
| Accounts Receivable | $29.3M | +19.1% |
| Current Assets | $220.2M | +167.6% |
| Total Assets | $359.5M | +202.8% |
| Current Liabilities | $42.4M | +26.1% |
| Total Liabilities | $58.8M | -71.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$54.0M | +21.7% |
| Capital Expenditures | $5.0M | +15.3% |
| Investing Cash Flow | -$238.6M | -5375.5% |
| Financing Cash Flow | $286.0M | — |
| Free Cash Flow | -$59.0M | +19.5% |
| -21.1% |
| EPS (Basic) | -$3.17 | +82.4% |
| EPS (Diluted) | -$3.17 | +82.4% |
| Stockholders' Equity |
| $300.6M |
| +135.0% |